TaiGen Biopharmaceuticals Holdings Limited (4157.TWO)
TWD 9.68
(-9.95%)
TWD 9.68
(-9.95%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 111.68 Million TWD | 158.76% |
| 2022 | 32.49 Million TWD | -97.46% |
| 2021 | 1.28 Billion TWD | 6512.0% |
| 2020 | 19.38 Million TWD | 52.53% |
| 2019 | 12.71 Million TWD | -51.22% |
| 2018 | 26.05 Million TWD | -95.24% |
| 2017 | 546.95 Million TWD | 318.71% |
| 2016 | 130.63 Million TWD | 124.7% |
| 2015 | 58.13 Million TWD | -33.2% |
| 2014 | 87.03 Million TWD | 59.39% |
| 2013 | 54.6 Million TWD | 93.01% |
| 2012 | 28.29 Million TWD | -85.62% |
| 2011 | 196.75 Million TWD | 5750.67% |
| 2010 | 3.36 Million TWD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 7000.00 TWD | -94.26% |
| 2024 Q2 | 117.37 Million TWD | 1676671.43% |
| 2023 Q3 | 5.75 Million TWD | -94.01% |
| 2023 FY | 84.08 Million TWD | 158.76% |
| 2023 Q1 | 3.18 Million TWD | 2.88% |
| 2023 Q2 | 96.19 Million TWD | 2922.94% |
| 2023 Q4 | 122 Thousand TWD | -97.88% |
| 2022 Q3 | 18.02 Million TWD | 822.2% |
| 2022 FY | 32.49 Million TWD | -97.46% |
| 2022 Q1 | 9.41 Million TWD | 13352.86% |
| 2022 Q2 | 1.95 Million TWD | -79.24% |
| 2022 Q4 | 3.09 Million TWD | -82.84% |
| 2021 Q4 | 70 Thousand TWD | -96.18% |
| 2021 FY | 1.28 Billion TWD | 6512.0% |
| 2021 Q2 | 1.24 Billion TWD | 3350.74% |
| 2021 Q3 | 1.83 Million TWD | -99.85% |
| 2021 Q1 | 36.04 Million TWD | 372.8% |
| 2020 Q3 | 4.19 Million TWD | -1.2% |
| 2020 Q1 | 3.32 Million TWD | 7.65% |
| 2020 Q4 | 7.62 Million TWD | 81.74% |
| 2020 FY | 19.38 Million TWD | 52.53% |
| 2020 Q2 | 4.24 Million TWD | 27.85% |
| 2019 Q3 | 3.4 Million TWD | 12.51% |
| 2019 Q1 | 3.2 Million TWD | -0.68% |
| 2019 Q2 | 3.02 Million TWD | -5.65% |
| 2019 Q4 | 3.08 Million TWD | -9.26% |
| 2019 FY | 12.71 Million TWD | -51.22% |
| 2018 Q1 | 16.12 Million TWD | 704.94% |
| 2018 Q4 | 3.22 Million TWD | -23.25% |
| 2018 Q3 | 4.2 Million TWD | 67.81% |
| 2018 Q2 | 2.5 Million TWD | -84.47% |
| 2018 FY | 26.05 Million TWD | -95.24% |
| 2017 FY | 546.95 Million TWD | 318.71% |
| 2017 Q2 | 529.01 Million TWD | 4488.16% |
| 2017 Q1 | 11.53 Million TWD | -78.65% |
| 2017 Q3 | 4.41 Million TWD | -99.17% |
| 2017 Q4 | 2 Million TWD | -54.58% |
| 2016 Q2 | 45.36 Million TWD | 226.53% |
| 2016 Q3 | 17.35 Million TWD | -61.75% |
| 2016 FY | 130.63 Million TWD | 124.7% |
| 2016 Q4 | 54.01 Million TWD | 211.22% |
| 2016 Q1 | 13.89 Million TWD | -2.08% |
| 2015 Q2 | 14.6 Million TWD | -0.55% |
| 2015 Q4 | 14.18 Million TWD | -3.13% |
| 2015 Q3 | 14.64 Million TWD | 0.27% |
| 2015 Q1 | 14.69 Million TWD | 1.23% |
| 2015 FY | 58.13 Million TWD | -33.2% |
| 2014 Q2 | 13.96 Million TWD | -68.55% |
| 2014 Q1 | 44.41 Million TWD | 218.29% |
| 2014 Q4 | 14.51 Million TWD | 2.62% |
| 2014 FY | 87.03 Million TWD | 59.39% |
| 2014 Q3 | 14.14 Million TWD | 1.24% |
| 2013 Q2 | 13.73 Million TWD | 3.37% |
| 2013 Q4 | 13.95 Million TWD | 2.35% |
| 2013 Q3 | 13.63 Million TWD | -0.71% |
| 2013 FY | 54.6 Million TWD | 93.01% |
| 2013 Q1 | 13.28 Million TWD | 0.77% |
| 2012 Q4 | 13.18 Million TWD | 0.9% |
| 2012 Q3 | 13.06 Million TWD | 0.0% |
| 2012 FY | 28.29 Million TWD | -85.62% |
| 2011 FY | 196.75 Million TWD | 5750.67% |
| 2010 FY | 3.36 Million TWD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | -33847.112% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 402.54 Million TWD | 72.255% |
| Level Biotechnology Inc. | 219.54 Million TWD | 49.128% |
| Sagittarius Life Science Corp | 71.47 Million TWD | -56.254% |
| NeoCore Technology Co., Ltd. | -9.08 Million TWD | 1329.345% |
| TaiMed Biologics Inc. | 225.23 Million TWD | 50.413% |
| GlycoNex Incorporation | 995 Thousand TWD | -11124.724% |
| VBI | 16.42 Million TWD | -580.058% |
| GeneReach Biotechnology Corp. | 27.58 Million TWD | -304.894% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 198.45 Million TWD | 43.722% |
| SynCore Biotechnology Co.,Ltd | 521 Thousand TWD | -21336.852% |
| Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | 6.858% |
| Visgeneer Inc. | 67.48 Million TWD | -65.505% |
| Mycenax Biotech Inc. | -375.19 Million TWD | 129.768% |
| Sunmax Biotechnology Co., Ltd. | 1.4 Billion TWD | 92.05% |
| G&E Herbal Biotechnology Co., Ltd. | 144.58 Million TWD | 22.755% |
| Neith Corporation | 18.01 Million TWD | -519.824% |
| Medigen Vaccine Biologics Corporation | 230.22 Million TWD | 51.488% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 22.74 Million TWD | -391.1% |
| Enimmune corporation | -23.37 Million TWD | 577.842% |
| TaiRx, Inc. | 2.43 Million TWD | -4479.172% |
| CHO Pharma, Inc. | -28.27 Million TWD | 494.943% |
| EirGenix Inc. | 236.74 Million TWD | 52.824% |
| BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | -7.029% |
| Sunny Pharmtech Inc. | 285.52 Million TWD | 60.884% |
| Lin BioScience, Inc. | -17.92 Million TWD | 723.004% |
| BioGend Therapeutics Co., Ltd. | 89.61 Million TWD | -24.625% |
| Feng Chi Biotech Corp. | 80.72 Million TWD | -38.361% |
| Bio Preventive Medicine Corp. | 1.08 Million TWD | -10212.65% |
| Lukas Biomedical Inc. | 133.89 Million TWD | 16.584% |
| RBC Bioscience Corporation | 72.89 Million TWD | -53.215% |
| BiOptic Inc. | 152.74 Million TWD | 26.881% |
| BRIM Biotechnology, Inc. | 90 Thousand TWD | -123995.556% |
| Shine-On BioMedical Co.,Ltd. | 6.66 Million TWD | -1575.206% |
| Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | -4170.975% |
| Syngen Biotech Co.,Ltd. | 643.91 Million TWD | 82.655% |
| Advagene Biopharma Co., Ltd. | -12 Million TWD | 1030.562% |
| NaviFUS Corp. | 11.82 Million TWD | -844.331% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 96.77 Million TWD | -15.409% |
| Sinew Pharma Inc. | -28.98 Million TWD | 485.323% |
| Andros Pharmaceuticals Co.,Ltd | 313 Thousand TWD | -35582.428% |
| Greenyn Biotechnology Co., Ltd | 392.45 Million TWD | 71.542% |
| Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | -169.246% |
| AP Biosciences Inc | 32.25 Million TWD | -246.281% |
| Medigen Biotechnology Corp. | 617.32 Million TWD | 81.908% |
| 3D Global Biotech Inc. | 5.27 Million TWD | -2017.672% |
| Pharmosa Biopharm Inc. | 314.5 Million TWD | 64.488% |
| Intech Biopharm Corporation | -163.99 Million TWD | 168.103% |
| Oneness Biotech Co., Ltd. | 32.56 Million TWD | -242.995% |
| Eusol Biotech Co.,Ltd. | -4.02 Million TWD | 2872.053% |
| TWi Biotechnology, Inc. | -9.73 Million TWD | 1246.791% |
| Ever Supreme Bio Technology Co., Ltd | 484.75 Million TWD | 76.96% |
| TCI GENE Inc. | 174.61 Million TWD | 36.039% |
| MegaPro Biomedical Co., Ltd | -16.6 Million TWD | 772.767% |
| Senhwa Biosciences, Inc. | -10.17 Million TWD | 1197.867% |
| Taiwan Bio Therapeutics Co., Ltd | 76.35 Million TWD | -46.264% |
| NatureWise Biotech & Medicals Corporation | 76.96 Million TWD | -45.116% |
| PharmaEngine, Inc. | 718.97 Million TWD | 84.466% |
| Savior Lifetec Corporation | 220.94 Million TWD | 49.452% |
| OBI Pharma, Inc. | -73.49 Million TWD | 251.96% |
| Meribank Biotech Co., Ltd | 138.87 Million TWD | 19.575% |
| Acepodia, Inc. | 16.59 Million TWD | -573.091% |
| Caliway Biopharmaceuticals Co., Ltd. | 27.46 Million TWD | -306.589% |